By Adriano Marchese Shares of Liquidia were down in premarket trading on Thursday after it said that the U.S. Food and Drug Administration is still working.
By Chris Wack Mineralys Therapeutics shares were up 11% to $8.27 after the company said that the first subject has been dosed in a Phase 3 trial to evaluate.
By Dominic Chopping Novo Nordisk has agreed to acquire a drug being developed to treat uncontrolled hypertension, which could also help cardiovascular and.